GYNECOLOGICAL ENDOCRINOLOGY is a prestigious open-access journal published by Taylor & Francis Ltd, focusing on the dynamic fields of endocrinology, obstetrics, and gynecology. With its ISSN of 0951-3590 and E-ISSN of 1473-0766, this journal provides a vital platform for the dissemination of high-quality research and advancements in gynecological endocrinology since its inception in 1987. Notably, it attained an Open Access status in 2023, enhancing its reach and accessibility to researchers and practitioners worldwide. The journal is renowned for its rigorous peer-review process and holds significant standing with a Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Endocrinology, Diabetes, and Metabolism, as of 2023. It is indexed with commendable Scopus ranks in various medical domains, offering a reliable resource for current methodologies and future directions in gynecological health. With the growing emphasis on women's health and endocrinological research, GYNECOLOGICAL ENDOCRINOLOGY serves as an essential repository for innovative studies, clinical insights, and emerging therapeutic strategies, making it an invaluable resource for researchers, clinicians, and students alike.

Archives of Endocrinology Metabolism is a distinguished open-access journal dedicated to advancing the field of endocrinology and metabolism. Published by SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA, this journal has established itself as a vital platform for researchers, clinicians, and scholars since its inception in 2008. With an ISSN of 2359-3997 and E-ISSN of 2359-4292, it aims to disseminate high-quality research articles that explore the latest advancements in endocrinology, diabetes, and metabolism. As of 2023, it has achieved a commendable Q3 ranking in its field, demonstrating its relevancy and increasing visibility among peers. The journal's focus spans various sub-disciplines, including hormonal regulation, metabolic disorders, and innovative therapies, making it an essential resource for both emerging professionals and seasoned experts alike. With a rich repository of research from Brazil and beyond, Archives of Endocrinology Metabolism continuously seeks to contribute to the ongoing dialogue and collaboration within the global scientific community.

MATURITAS is a leading international journal dedicated to promoting high-quality research in the fields of Obstetrics and Gynecology, and Biochemistry, Genetics, and Molecular Biology. Published by Elsevier Ireland Ltd, this prestigious journal boasts an impressive impact factor, consistently ranking in the Q1 quartile in both categories, underscoring its critical role in advancing scientific knowledge and clinical practices. Established in 1978 and spanning through to 2024, MATURITAS facilitates the dissemination of innovative findings and provides crucial insights into women's health and reproductive issues. Researchers, professionals, and students can engage with a wealth of resources, as the journal embraces a wide range of accessible options to foster scholarly communication. With ranks of #10 out of 209 in Medicine and #38 out of 221 in General Biochemistry, Genetics and Molecular Biology according to Scopus, MATURITAS remains at the forefront of research, making it an invaluable resource for those eager to contribute to and expand their understanding in these vital fields.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY is a distinguished peer-reviewed journal published by Pergamon-Elsevier Science Ltd, committed to advancing the fields of biochemistry, molecular biology, and endocrinology. With an ISSN of 0960-0760 and an E-ISSN of 1879-1220, this journal has garnered a notable reputation, securing a Q2 ranking in numerous categories, including Biochemistry, Cell Biology, and Clinical Biochemistry, as of 2023. Hailing from the United Kingdom, it serves as a critical platform for the dissemination of impactful research from 1990 to 2025 and beyond. Although it does not currently offer open access options, the journal's comprehensive coverage and rigorous peer review process ensure high-quality publications that significantly contribute to the understanding of steroid biochemistry and related fields. Targeting a diverse audience of researchers, professionals, and students, the journal remains an essential resource for those seeking to stay at the forefront of scientific innovation and discovery.

ANDROLOGIA is a distinguished journal published by Wiley, focusing on the vital fields of andrology, urology, and endocrinology. Since its inception in 1969, this journal has become a key resource for researchers, clinicians, and students, striving to advance the understanding of male reproductive health and related disorders. With an impressive impact factor and recognition in category quartiles such as Q2 in both Medicine (miscellaneous) and Urology for 2023, ANDROLOGIA has established itself as a leading platform, ranking 16th out of 120 in Urology. Though not an open-access journal, it offers valuable insights through a rigorous peer-review process and a commitment to disseminating high-quality research. The journal's scope is broad, encompassing all aspects of andrology and its implications within medicine, ensuring it remains relevant to the evolving landscape of health sciences. Researchers looking to publish their work or keep abreast of recent discoveries will find ANDROLOGIA an essential addition to their academic resources.

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM is a leading academic journal published by Elsevier that focuses on the dynamic field of endocrinology and metabolism. With an impressive impact factor reflected in its Q1 ranking in both endocrinology and endocrinology, diabetes, and metabolism for 2023, this journal is essential for researchers, healthcare professionals, and students seeking to stay abreast of the most significant developments in clinical practice and research. Covering a wide range of topics within the scope of endocrinology, the journal provides a platform for innovative research, comprehensive reviews, and insightful case studies, all aimed at enhancing patient care and advancing the field. With robust rankings, including a position of 22nd out of 244 in Endocrinology and a 90th percentile ranking in Biochemistry, Genetics, and Molecular Biology, this journal is recognized for its scholarly contribution and relevance. As an open-access journal, it ensures that valuable research is accessible to a global audience, advancing knowledge and clinical practice in endocrinology.

Sexual Medicine, published by Oxford University Press, is a leading open-access journal dedicated to advancing the field of sexual health and medicine since its inception in 2013. With an E-ISSN of 2050-1161, this journal provides a platform for high-quality research that spans multiple disciplines including Behavioral Neuroscience, Dermatology, Endocrinology, Psychiatry and Mental Health, and Reproductive Medicine. Notably, the journal has maintained a solid standing in its category quartiles, with rankings reflecting its significant impact in the fields of Urology (Rank #18/120, 85th Percentile) and Reproductive Medicine (Rank #25/90, 72nd Percentile), among others. The open-access model enhances accessibility to groundbreaking research, ensuring that knowledge is disseminated widely to researchers, healthcare professionals, and students alike. With a commitment to fostering a deeper understanding of the complexities surrounding sexual health, Sexual Medicine endeavors to provide critical insights and foster discussions that drive innovation and improvement in clinical practices. Discover more and stay updated on the latest findings in sexual health by engaging with this invaluable resource on a global scale.

INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, published by SpringerNature, stands as a revered platform in the field of urology, particularly focusing on issues related to male sexual health and dysfunction. Since its inception in 1993, this journal has consistently provided cutting-edge research, reviews, and clinical studies, all directed towards advancing our understanding of impotence and related conditions. With an impressive ranking of 26th out of 120 journals in the Scopus category of Medicine_Urology (percentile 78th), it holds a crucial place as a Q2 journal, reflecting its substantial impact and influence in the field. Researchers, professionals, and students alike can benefit from the wealth of knowledge presented in its pages, contributing to their studies and clinical applications. While the journal is not open access, it ensures high-quality content curated by leading experts, fostering essential discourse in an often stigmatized yet significant area of health.

Hormones - International Journal of Endocrinology and Metabolism, published by Springer International Publishing AG, is a vital resource within the field of Endocrinology, Diabetes, and Metabolism. Since its inception in 2005, this journal has made significant contributions to the understanding of hormonal mechanisms and their implications across various medical disciplines. With a current impact factor that places it in the Q3 category for Endocrinology and the Q2 category for miscellaneous Medicine – as indicated by its Scopus rankings – it stands out as a reputable platform for cutting-edge research and clinical findings. Although it operates under a subscription model, the journal's comprehensive scope encompasses basic and applied scientific studies, making it essential reading for researchers, clinicians, and students alike. The journal is headquartered in Germany with a strong commitment to promoting scholarly communication and knowledge dissemination within its specialized fields through the year 2024 and beyond.

HORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.